FIELD: medicine, pharmaceutics.
SUBSTANCE: invention belongs to pharmaceutics, notably to solid pharmaceutical composition containing (R)-(-)-2-[5-(4-fluorophenyl)-3-piridylmethylaminimethyl]chroman as an active compound and at least one sugar alcohol (e.g. mannitol, sorbitol) as excipient, and to obtaining of solid pharmaceutical composition.
EFFECT: composition has enhanced storage stability even at higher temperature.
13 cl, 5 tbl, 5 ex
Title | Year | Author | Number |
---|---|---|---|
PHARMACEUTICAL COMPOSITIONS CONTAINING S1P RECEPTOR MODULATOR | 2007 |
|
RU2487703C2 |
PHARMACEUTICAL COMPOSITION IN SOLID FORM WITH ANALGESIC ACTIVITY | 2013 |
|
RU2545861C1 |
STABLE PHARMACEUTICAL COMPOSITION CONTAINING WATER-SOLUBLE VINFLUNINE SALT | 2008 |
|
RU2462248C2 |
PHARMACEUTICAL COMPOSITION CONTAINING N-[3-CHLOR-4-[(3-FLUOROPHENYL)METHOXY]PHENYL]-6-[5[[[2-(METHYLSULPHONYL)ETHYL]AMINO]METHYL]-2-FURYL]-4-QUINAZOLINAMINE | 2009 |
|
RU2548757C2 |
NOVEL USING 2-[5-(4-FLUOROPHENYL)-3-PYRIDYLMETHYLAMINOMETHYL]-CHROMAN AND ITS PHYSIOLOGICALLY ACCEPTABLE SALTS | 2002 |
|
RU2297833C2 |
PHARMACOLOGICAL COMPOSITION WITH SWELLING COATING | 2004 |
|
RU2375048C2 |
PHARMACEUTICAL COMPOSITIONS OF METABOTROPIC GLUTAMATE RECEPTOR 5 (MGLU5) ANTAGONISTS | 2011 |
|
RU2602955C2 |
PHARMACEUTICAL COMPOSITIONS WITH PROLONGED RELEASE FOR TREATING CEREBROVASCULAR DISORDERS | 2014 |
|
RU2611339C2 |
ORGANIC COMPOUNDS | 2004 |
|
RU2358716C2 |
POLYOL COMPOSITION | 1997 |
|
RU2184535C2 |
Authors
Dates
2010-12-10—Published
2006-06-09—Filed